NASDAQ: BCAL
California Bancorp Stock

$19.04+0.08 (+0.42%)
Updated Nov 14, 2025
BCAL Price
$19.04
Fair Value Price
N/A
Market Cap
$615.42M
52 Week Low
$11.87
52 Week High
$19.39
P/E
8.73x
P/B
1.09x
P/S
2.88x
PEG
N/A
Dividend Yield
N/A
Revenue
$188.08M
Earnings
$63.41M
Gross Margin
100%
Operating Margin
47.23%
Profit Margin
33.7%
Debt to Equity
6.26
Operating Cash Flow
$60M
Beta
0.75
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

BCAL Overview

Southern California Bancorp operates as the holding company for Bank of Southern California, N.A. that provides various financial products to individuals, professionals, and small-to medium-sized businesses. The company offers checking, personal and business savings, and money market accounts, as well as certificates of deposit. It also provides home equity lines of credit, business loans and lines of credit, commercial real estate and construction loans, small business administration loans, letters of credit, and personal and business credit cards. In addition, the company provides cash vault, sweep accounts, and remote deposit capture services; online and mobile banking services; courier service; lockbox services; and merchant services. It operates branches in San Diego, Orange, Ventura, Los Angeles, and Riverside counties, as well as the Inland Empire. The company was founded in 2001 and is headquartered in San Diego, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine BCAL's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Bank

Industry Rating
D
BCAL
Ranked
#163 of 279

Top Ranked Stocks in Industry

View Top Bank Stocks

Be the first to know about important BCAL news, forecast changes, insider trades & much more!

BCAL News

Overview

Due Diligence Score

Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BCAL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BCAL is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BCAL is good value based on its earnings relative to its share price (8.73x), compared to the US market average (44.99x)
P/E vs Market Valuation
BCAL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more BCAL due diligence checks available for Premium users.

Valuation

BCAL fair value

Fair Value of BCAL stock based on Discounted Cash Flow (DCF)

Price
$19.04
Fair Value
$53.86
Undervalued by
64.65%
BCAL is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BCAL price to earnings (PE)

For valuing profitable companies with steady earnings

Company
8.73x
Industry
15.57x
Market
44.99x
BCAL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BCAL is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

BCAL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.09x
Industry
1.23x
BCAL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BCAL's financial health

Profit margin

Revenue
$45.2M
Net Income
$15.7M
Profit Margin
34.7%
BCAL's Earnings (EBIT) of $88.82M... subscribe to Premium to read more.
Interest Coverage Financials
BCAL's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$4.1B
Liabilities
$3.5B
Debt to equity
6.26
BCAL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$16.0M
Investing
-$12.6M
Financing
$125.7M
BCAL's operating cash flow ($60.01M)... subscribe to Premium to read more.
Debt Coverage Financials

BCAL vs Bank Stocks

TickerZen RatingMarket Cap1d %P/EP/B
BCALC$615.42M+0.42%8.73x1.09x
SPFIC$614.33M-0.24%10.33x1.29x
SMBKC$613.18M+0.59%13.00x1.14x
SMBCC$609.85M-0.68%9.93x1.09x
FCBCD$601.83M-0.45%12.22x1.18x

California Bancorp Stock FAQ

What is California Bancorp's quote symbol?

(NASDAQ: BCAL) California Bancorp trades on the NASDAQ under the ticker symbol BCAL. California Bancorp stock quotes can also be displayed as NASDAQ: BCAL.

If you're new to stock investing, here's how to buy California Bancorp stock.

What is the 52 week high and low for California Bancorp (NASDAQ: BCAL)?

(NASDAQ: BCAL) California Bancorp's 52-week high was $19.39, and its 52-week low was $11.87. It is currently -1.81% from its 52-week high and 60.4% from its 52-week low.

How much is California Bancorp stock worth today?

(NASDAQ: BCAL) California Bancorp currently has 32,322,651 outstanding shares. With California Bancorp stock trading at $19.04 per share, the total value of California Bancorp stock (market capitalization) is $615.42M.

California Bancorp stock was originally listed at a price of $13.50 in May 11, 2023. If you had invested in California Bancorp stock at $13.50, your return over the last 2 years would have been 41.04%, for an annualized return of 18.76% (not including any dividends or dividend reinvestments).

How much is California Bancorp's stock price per share?

(NASDAQ: BCAL) California Bancorp stock price per share is $19.04 today (as of Nov 14, 2025).

What is California Bancorp's Market Cap?

(NASDAQ: BCAL) California Bancorp's market cap is $615.42M, as of Nov 15, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

California Bancorp's market cap is calculated by multiplying BCAL's current stock price of $19.04 by BCAL's total outstanding shares of 32,322,651.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.